SCHEMBL1807965

SCHEMBL1807965

CCOc1cc(OC)cc2ncnc(NCc3cc(S(N)(=O)=O)ccc3OC(F)(F)F)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 6/20 0.46
BRAF P15056 5/20 0.46
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
LMNA P02545 4/20 0.39
SRC P12931 1/20 0.37
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C19 P33261 3/20 0.35
USP2 O75604 2/20 0.35
CYP2C9 P11712 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1807652 0.94 TNNI3K (0.52) TNNI3KBRAFSLC6A4SLC6A3LMNA
SCHEMBL1807400 0.91 TNNI3K (0.55) TNNI3KBRAFLMNASRCCA1
SCHEMBL1809500 0.86 BRAF (0.53) TNNI3KBRAFLMNASRCCA1
SCHEMBL1808559 0.84 TNNI3K (0.62) TNNI3KBRAFLMNASRCCA1
Hydrochloric Acid SCHEMBL1804254 0.84 TNNI3K (0.61) TNNI3KBRAFLMNASRCCA1
Hydrochloric Acid SCHEMBL1804960 0.82 BRAF (0.49) TNNI3KBRAFLMNASRCCYP1A2
SCHEMBL1806390 0.81 MAPK1 (0.54) TNNI3KBRAFLMNAMAPK1ALDH1A1
SCHEMBL1806719 0.79 BRAF (0.46) TNNI3KBRAFLMNASRCCA1
SCHEMBL1804276 0.78 BRAF (0.45) TNNI3KBRAFSLC6A4LMNASRC
Trifluoroacetic Acid SCHEMBL1805887 0.78 BRAF (0.46) TNNI3KBRAFLMNASRCCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP claimed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO claimed
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP disclosed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed